SEC Form 4 · accession 0001225208-18-009494

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Larry L Wood

Officer — CVP, THV Replacement

Period of report

May 14, 2018

Accepted (ET)

May 16, 2018 · 8:49 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001099800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	May 14, 2018	F	1,066	$138.11	D	108,936	D
Common Stock	May 15, 2018	M	6,300	$42.725	A	115,236	D
Common Stock	May 15, 2018	S	6,300	$137.26	D	108,936	D
Common Stock^F3	holding	—	—		—	165	I	401(k)

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Acquire)	$42.725	May 15, 2018	M	6,300	D	May 9, 2013	May 8, 2019	Common Stock	6,300	44,100	D

Explanation of responses

F1This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator
F2The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 31, 2017.
F3Shares represented on the most recent statement of the 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equity to share equivalents.

Remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.